Saudi Press

Saudi Arabia and the world
Saturday, Aug 02, 2025

German expert panel says under-60s who got first AstraZeneca shot should receive DIFFERENT vaccine for second jab

German expert panel says under-60s who got first AstraZeneca shot should receive DIFFERENT vaccine for second jab

A German expert panel has recommended those who received one AstraZeneca jab should take another vaccine as their second dose, since the British jab’s side effects could be more dangerous than taking two different products.

All Germans under 60 “should be given a dose of an mRNA vaccine 12 weeks after the first vaccination instead of the second AstraZeneca … dose,” the German Government’s Standing Committee on Vaccination (STIKO) said in its latest draft recommendation published on Thursday. The jabs produced by Pfizer-BioNTech and Moderna were mentioned as possible substitutes.

“So far, no data are available on the risk of the second vaccination [with AstraZeneca],” the expert panel admits, adding that “scientific evidence” on safety and effectiveness of vaccination with two different jabs is also lacking. Still, STIKO recommended the second option for that age group.

AstraZeneca’s Vaxzevria jab can only be given to those under 60 “at the discretion of the doctor” and after a patient accepts all potential risks, the panel concluded.

The rather unorthodox advice, which implies that millions of people might potentially be forced to rely on a yet-untested vaccination strategy, comes amid serious concerns related to the British-Swedish vaccine’s potential serious side effects.

“At the moment, one can only speculate about the risk of having been vaccinated twice,” Thomas Mertens, the head of STIKO, told Der Spiegel on Thursday referring to the Vaxzevria jab.

"The obvious way out is not to try it at all but to give an mRNA vaccine as an alternative to be on the safe side."


A virologist and the former medical director of the Ulm University Hospital, Mertens also said that the results of animal experiments available so far “show that the immune response is the same” after vaccination with two different shots.

He admitted, though, that the researchers still “have to scientifically clarify” whether the protection would be just as good in humans. He also said that “there will be data on this soon.”

STIKO had announced on Tuesday that Vaxzevria can only be given to over-60s. The decision came after Germany's vaccine regulator, the Paul Ehrlich Institute, disclosed that as of March 29, the country has recorded 31 cases of cerebral sinus vein thrombosis (CSVT), nine of which resulted in death, after people took the Vaxzevria shots. CSVT is a rare form of blood clot that forms in the brain.

Mertens called the regulator’s report a “very clear signal” which STIKO had to react to. The report also suggested that people under 60 appear more likely to be affected by this particular side effect. He also cited the data provided by Norway that suggested the jab provoked CSVT “at a ratio of 1 to 25,000 vaccinations.”

Some 2.8 million Germans already received their first Vaxzevria shot. Only around 2,000 people took the second shot too, according to German media. According to official figures, women under the age of 70 make up two-thirds of those vaccinated with the AstraZeneca drug. Some reports attribute this statistic to a fact that nurses were one of the primary groups to get it.

Earlier, dozens of nations in Europe and beyond temporarily halted the use of the vaccine following the reports of fatal blood clotting. Both the European Medicines Agency (EMA) and the World Health Organization have both said that they consider Vaxzevria safe to use, however, with benefits outweighing the risks of rare side-effects.

Newsletter

Related Articles

Saudi Press
0:00
0:00
Close
IMF Upgrades Global Growth Forecast as Weaker Dollar Supports Outlook
Politics is a good business: Barack Obama’s Reported Net Worth Growth, 1990–2025
"Crazy Thing": OpenAI's Sam Altman Warns Of AI Voice Fraud Crisis In Banking
Japanese Prime Minister Vows to Stay After Coalition Loses Upper House Majority
President Trump Diagnosed with Chronic Venous Insufficiency After Leg Swelling
Man Dies After Being Pulled Into MRI Machine Due to Metal Chain in New York Clinic
FIFA Pressured to Rethink World Cup Calendar Due to Climate Change
"Can You Hit Moscow?" Trump Asked Zelensky To Make Putin "Feel The Pain"
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
Iranian President Reportedly Injured During Israeli Strike on Secret Facility
Kurdistan Workers Party Takes Symbolic Step Towards Peace in Northern Iraq
BRICS Expands Membership with Indonesia and Ten New Partner Countries
Elon Musk Founds a Party Following a Poll on X: "You Wanted It – You Got It!"
AI Raises Alarms Over Long-Term Job Security
Saudi Arabia Maintains Ties with Iran Despite Israel Conflict
Russia Formally Recognizes Taliban Government in Afghanistan
Mediators Edge Closer to Israel-Hamas Ceasefire Agreement
Emirates Airline Expands Market Share with New $20 Million Campaign
House Oversight Committee Subpoenas Former Jill Biden Aide Amid Investigation into Alleged Concealment of President Biden's Cognitive Health
Amazon Reaches Major Automation Milestone with Over One Million Robots
Meta Announces Formation of Ambitious AI Unit, Meta Superintelligence Labs
China Unveils Miniature Insect-Like Surveillance Drone
Marc Marquez Claims Victory at Dutch Grand Prix Amidst Family Misfortune
Iran Executes Alleged Israeli Spies and Arrests Hundreds Amid Post-War Crackdown
Trump Asserts Readiness for Further Strikes on Iran Amid Nuclear Tensions
Iran's Parliament Votes to Suspend Cooperation with Nuclear Watchdog
Trump Announces Upcoming US-Iran Meeting Amid Controversial Airstrikes
Trump Moves to Reshape Middle East Following Israel-Iran Conflict
NATO Leaders Endorse Plan for Increased Defence Spending
U.S. Crude Oil Prices Drop Below $65 Amid Market Volatility
Explosions Rock Doha as Iranian Missiles Target Qatar
“You Have 12 Hours to Flee”: Israeli Threat Campaign Targets Surviving Iranian Officials
Oman Set to Introduce Personal Income Tax, First in Gulf
Germany and Italy Under Pressure to Repatriate $245bn of Gold from US Vaults
Iran Intensifies Crackdown on Alleged Mossad Operatives After Sabotage Claims
Trump Praises Iran’s ‘Very Weak’ Response After U.S. Strikes and Presses Israel to Pursue Peace
WATCH: Israeli forces show the aftermath of a massive airstrike at Iran's Isfahan nuclear site
We have new information and breaking details to share about what is shaping up to be a historic air campaign tonight
Six Massive Bombs Dropped on Fordow; Trump: 'A Historic Moment for the U.S., Israel, and the World'
Fordow: Deeply Buried Iranian Enrichment Site in U.S.–Israel Crosshairs
United States Conducts Precision Strikes on Iran’s Nuclear Sites
US strikes Iran nuclear sites, Trump says
Pakistan to nominate Trump for Nobel Peace Prize.
Israel Confirms Assassination of Quds Force Commander in Tehran
16 Billion Login Credentials Leaked in Unprecedented Cybersecurity Breach
Senate hearing on who was 'really running' Biden White House kicks off
G7 Leaders Fail to Reach Consensus on Key Global Issues
Mass exodus in Tehran as millions try to flee following Trump’s evacuation order
Iranian Military Officers Reportedly Seek Contact with Reza Pahlavi, Signal Intent to Defect
Vietnam Emerges as Luxury Yacht Destination for Ultra‑Rich
×